Money A2Z Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Athersys (ATHX) Q4 Earnings: What's in Store for the Stock? - AOL

    www.aol.com/news/athersys-athx-q4-earnings-whats...

    During Athersys' (ATHX) Q4 conference call, investor focus will be on the company's progress with its investigational MultiStem cell therapy to treat various indications.

  3. Are Options Traders Betting on a Big Move in Athersys (ATHX ...

    www.aol.com/news/options-traders-betting-big...

    Investors need to pay close attention to Athersys (ATHX) stock based on the movements in the options market lately.

  4. Athersys (ATHX) Down as Ischemic Stroke Study Fails to ... - AOL

    www.aol.com/news/athersys-athx-down-ischemic...

    While a mid-stage/late-stage study evaluating Athersys' (ATHX) stem cell treatment for ischemic stroke misses out on its primary endpoint, top-line data shows evidence of therapeutic impact.

  5. List of major stock exchanges - Wikipedia

    en.wikipedia.org/wiki/List_of_major_stock_exchanges

    List of major stock exchanges. This is a list of major stock exchanges. Those futures exchanges that also offer trading in securities besides trading in futures contracts may be listed both here and in the list of futures exchanges . There are twenty one stock exchanges in the world that have a market capitalization of over US$1 trillion each.

  6. Athersys, Inc. (ATHX) Upgraded to Buy: Here's Why - AOL

    www.aol.com/news/athersys-inc-athx-upgraded-buy...

    For premium support please call: 800-290-4726 more ways to reach us

  7. Implied Volatility Surging for Athersys (ATHX) Stock Options

    www.aol.com/news/implied-volatility-surging...

    For premium support please call: 800-290-4726 more ways to reach us

  8. Athersys (ATHX) Upgraded to Strong Buy: Here's What You ... - AOL

    www.aol.com/news/athersys-athx-upgraded-strong...

    For premium support please call: 800-290-4726 more ways to reach us

  9. Athersys' (ATHX) MultiStem Cell Therapy Succeeds in Study - AOL

    www.aol.com/news/athersys-athx-multistem-cell...

    Athersys (ATHX) gains on encouraging results from its exploratory study on the intravenous administration of MultiStem cell therapy to treat patients suffering from ARDS.